CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...

CVS Health Corporation's Q1 2025 earnings show strong growth, with revenues up 7% YoY and adjusted EPS up 72%, but caution is advised for the long-term outlook. Despite positive quarterly results, CVS ...

CVS Health's recent earnings miss and revised guidance caused a steep sell-off in the stock, which now may present a buying opportunity for long-term investors. Despite the miss, the company saw ...

We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other ...